Table. Subject Characteristics (n=12) at Baseline.
| Age (years) | 57.3 (7.2, 40-65) |
| Gender (Male/Female) | 5M/7F |
| Education (years) | 18.2 (2.7, 13-24) |
| Age onset PD (years) | 44.5 (9.2) (24-56) |
| Age diagnosis PD (years) | 47.9 (8.2, 32-57) |
| Duration PD (years) | 12.8 (8.4, 3-34) |
| Hoehn & Yahr Stage | 2.1 (0.3) # subjects per stage I½=1, II=8, II½=3 |
| UPDRS ADL Subscore | 14.9 (12.1) |
| Motor Subscore | 23.2 (12.7) |
| Mean (SD, Range) | |
| Concomitant Medications | |||
|---|---|---|---|
| Antiparkinsonian Medications | Psychiatric Medications | ||
| Dopamine agonists only | 2 (17%) | Antidepressants | 7 (58%) |
| l-dopa only | 4 (33%) | Atypical Antipsychotics | 3 (25%) |
| l-dopa + Dopamine agonists | 6 (50%) | Benzodiazepine/hypnotics | 2 (17%) |
| Apomorphine | 1 (8%) | ||
| COMT inhibitor | 3 (25%) | ||
| Anticholinergics | 1 (8%) | ||
| Selegiline | 1 (8%) | ||
| Amantadine | 2 (17%) | ||